“Grand View Research, Inc. – Market Research And Consulting.”

The global regenerative medicine market size is expected to reach USD 5.60 billion by 2025, registering a CAGR of 11.6%, as per a new report by Grand View Research, Inc. The market is driven by a high prevalence of cancer, orthopedic, neurodegenerative, and other aging-associated diseases, coupled with expanding global geriatric population. 

Market players are engaged in employing novel protocols to derive advanced therapeutics. For instance, in July 2018, Convelo Therapeutics launched regenerative medicines for the treatment of various neurological diseases, such as multiple sclerosis. In March 2018, Hitachi Chemical collaborated with the Daiichi Sankyo and SanBio Group to initiate clinical manufacturing of regenerative medicines for Japanese and U.S. markets.

The market has found widespread application across tissue engineering, gene therapy, drug discovery, stem cells, and nanotechnology. For example, 3D printing is steadily replacing scaffold with stem cells to restore functional characteristics and structure of biological specimens.  Dermatology is a key application area and the segment held the largest revenue share in 2018. Oncology therapeutic segment is estimated to expand at the fastest CAGR in the coming years, owing to the strong pipeline of regenerative medicines present for cancer treatment.

Regenerative Medicine Market Highlights

1. The Korean government has established a blueprint to advance the country’s regenerative medicine clinical research, known as “K-regenerative medicine” over the next five years. This is expected to revitalize the foundation for experimental and clinical research by progressively expanding the regenerative medical institution designations from general hospitals to the level of local hospitals

2. In Januray 2021, the University of Texas launched collaborative research called the lnstitute of Regenerative Medicine that will solely leverage researchers to advance traditional regenerative medicine. The initiative is intended to benefit the patients suffering from CVD and other medical issues 

3. In January 2021, Medicine by Design entered in a partnership with H2i to support entrepreneurs by offering them with funded labs in the field of regenerative medicine. In addition, the venture is aimed to prepare Medicine by Design teams dedicated to developing incubators like the Creative Destruction Lab (CDL)

4. Stem cell and progenitor cell-based therapies are projected to witness a staggering growth rate due to high investments made in stem cell research, coupled with the rising number of stem cell banks

5. Asia Pacific is anticipated to showcase the fastest CAGR from 2019 to 2025 due to the rapid adoption of cell-based therapeutic approaches in healthcare, along with the emergence of key players 

“Would you Like/Try a Sample Report” Click the link below:https://www.grandviewresearch.com/industry-analysis/regenerative-medicine-market/request/rs1

Regenerative Medicine Market Segmentation

Grand View Research has segmented the global regenerative medicine market on the basis of product type, therapeutic category, and region:

Regenerative Medicine Product Type Outlook (Revenue, USD Million, 2014 – 2025)

• Therapeutics & Devices

• Primary Cell-bases Therapeutics

• Dermatology

• Musculoskeletal

• Surgical

• Dental

• Others

• Stem Cell & Progenitor Cell-based Therapeutics

• Autologous

• Allogeneic

• Others

• Cell-based Immunotherapies

• Gene Therapies

• Tools

• Banks

• Services

Regenerative Medicine Therapeutic Category Outlook (Revenue, USD Million, 2014 – 2025)

• Dermatology

• Musculoskeletal

• Immunology & Inflammation

• Oncology

• Cardiovascular

• Ophthalmology

• Others

Regenerative Medicine Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America

• U.S.

• Canada

• Europe

• Germany

• U.K.

• Asia Pacific

• China

• Japan

• Latin America

• Brazil

• Middle East & Africa

• South Africa

List of Key Players in Regenerative Medicine Market

1. Integra LifeSciences Corporation

2. MiMedx Group, Inc.

3. AstraZeneca

4. F. Hoffmann-La Roche Ltd

5. Merck & Co., Inc.

6. Pfizer Inc.

7. Baxter.

Have Any Query? Ask Our Experts for More Details on Report:https://www.grandviewresearch.com/inquiry/4557/ibb

Browse Related Report @

Biopreservation Market – https://www.grandviewresearch.com/industry-analysis/biopreservation-market

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research is a market research and consulting company based in the State of California with headquarters in San Francisco. The company offers consulting services tailored for business organizations to assist them with understanding and exploring their potential on a large scale. At the same time, Grand View Research caters to the individual research needs to provide a customized research service.
Grand View Research is fully committed to offer the best research services in the Industry. Our dedicated team of experienced analysts offer full capability and potential to precisely understand your research needs.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/regenerative-medicine-market